# Edwards Lifesciences Corp (EW) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Edwards Lifesciences Corp's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/EW/mda/fy2025/): filed 2026-02-25; accession 0001099800-26-000009 (https://www.sec.gov/Archives/edgar/data/1099800/000109980026000009/ew-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/EW/mda/fy2024/): filed 2025-02-28; accession 0001099800-25-000005 (https://www.sec.gov/Archives/edgar/data/1099800/000109980025000005/ew-20241231.htm)
- [FY 2023 MD&A](/company/EW/mda/fy2023/): filed 2024-02-12; accession 0001099800-24-000004 (https://www.sec.gov/Archives/edgar/data/1099800/000109980024000004/ew-20231231.htm)
- [FY 2022 MD&A](/company/EW/mda/fy2022/): filed 2023-02-13; accession 0001099800-23-000005 (https://www.sec.gov/Archives/edgar/data/1099800/000109980023000005/ew-20221231.htm)
- [FY 2021 MD&A](/company/EW/mda/fy2021/): filed 2022-02-14; accession 0001099800-22-000005 (https://www.sec.gov/Archives/edgar/data/1099800/000109980022000005/ew-20211231.htm)

Back to /company/EW/